Cintia Piccina, Chief Commercial Officer at Adaptimmune Therapeutics PLC (ADAP), sold 11,890 shares at $1.87 ($22K) on 2023-01-31, disclosed to the SEC on 2023-01-31.
Open-market sale of $22k ADAP by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADAP | SELL | 2024-06-18 | $23K | — | Filing → |
| ADAP | SELL | 2022-08-01 | $37K | — | Filing → |